Skip to main content
. 2019 Jul 4;10:732. doi: 10.3389/fneur.2019.00732

Figure 1.

Figure 1

(A,B) Transfected HEK-cells, N-methyl-D-aspartate (NMDA), immunofluorescence, (A) incubated with patients' CSF—showing no antibody binding, (B) positive control. (C,D) Differentiated Glioma stem cells SY5Y (human), immunofluorescence, (C) incubated with patients' CSF—showing no antibody binding, (D) positive control. (E,F) Astrocytes (rat), (E) incubated with patients' CSF (red = anti glial fibrillary acidic protein (GFAP)—showing no antibody binding, (F) positive control (green = anti aquaporin 4).